Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Resonant Frequency rTMS: A Novel Approach to Target Circuit Modulation in Major Depressive Disorder

NCT06572683 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT06572683
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06572683 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Resonant Frequency rTMS: A Novel Approach to Target Circuit Modulation in Major Depressive Disorder
Lead sponsor
University of California, Los Angeles
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
February 12, 2024
Completion date
October 31, 2028
Enrollment
84 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, mdd